Hepatitis C Market
According to Intent Market Research, the Hepatitis C Market is expected to grow from USD 23.7 Billion in 2024-e at a CAGR of 9.6% to touch USD 41.3 Billion by 2030. The Hepatitis C Market is dominated by key players such as, Gilead Sciences, Merck & Co., AbbVie, Bristol-Myers Squibb, Johnson & Johnson, and Roche.